Additive Orthopaedics commenced a multi-center clinical study to measure bone in-growth into 3D-printed bone segments.
Company leadership noted that the honeycomb lattice structures have demonstrated improvements in post-op success and potential bone in-growth vs. those achieved with current allograft wedge options. The company has implanted >200 individual devices since full product launch in 2016, and recently closed a Series A Round of US $1.0MM.
Additive Orthopaedics commenced a multi-center clinical study to measure bone in-growth into 3D-printed bone segments.
Company leadership noted that the honeycomb lattice structures have demonstrated improvements in post-op success and potential bone in-growth vs. those achieved with current allograft wedge options. The company has...
Additive Orthopaedics commenced a multi-center clinical study to measure bone in-growth into 3D-printed bone segments.
Company leadership noted that the honeycomb lattice structures have demonstrated improvements in post-op success and potential bone in-growth vs. those achieved with current allograft wedge options. The company has implanted >200 individual devices since full product launch in 2016, and recently closed a Series A Round of US $1.0MM.
Copy to clipboard 
